Rémy Gébleux

A novel anti-HER2 anthracycline-based antibody-drug conjugate induces adaptive anti-tumor immunity and potentiates PD-1 blockade in breast cancer

Lucia D’Amico, Ulrike Menzel, Michael Prummer et al. · Journal for ImmunoTherapy of Cancer · 2019 · 116 citations · Full text

Breast Oncology, Pd-1 Blockade, Adaptive Immune System +17

Non‐internalizing antibody–drug conjugates display potent anti‐cancer activity upon proteolytic release of monomethyl auristatin E in the subendothelial extracellular matrix

Rémy Gébleux, Marco Stringhini, Ruben Casanova et al. · International Journal of Cancer · 2016 · 109 citations · Full text

Immunology, Monomethyl Auristatin E, Tumor Biology +19

Protease-Cleavable Linkers Modulate the Anticancer Activity of Noninternalizing Antibody–Drug Conjugates

Alberto Dal Corso, Samuele Cazzamalli, Rémy Gébleux et al. · Bioconjugate Chemistry · 2017 · 83 citations · Full text

Highly Potent, Anthracycline-based Antibody–Drug Conjugates Generated by Enzymatic, Site-specific Conjugation

Nikolas Stefan, Rémy Gébleux, Lorenz Waldmeier et al. · Molecular Cancer Therapeutics · 2017 · 74 citations · Full text

A non-internalizing antibody-drug conjugate based on an anthracycline payload displays potent therapeutic activity in vivo

Alberto Dal Corso, Rémy Gébleux, Patrizia Murer et al. · Journal of Controlled Release · 2017 · 71 citations · Full text

Polymer-drug Conjugate, Medicine, Non-internalizing Antibody-drug Conjugate +7